ReviewFrontiers in molecular biosciences2026

Metabolic reprogramming-related drug resistance in osteosarcoma: from molecular mechanisms to therapeutic translation.

Qun Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.